Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

79 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer's disease: A 24-week, randomized, double-blind study.
Farlow MR, Salloway S, Tariot PN, Yardley J, Moline ML, Wang Q, Brand-Schieber E, Zou H, Hsu T, Satlin A. Farlow MR, et al. Among authors: satlin a. Clin Ther. 2010 Jul;32(7):1234-51. doi: 10.1016/j.clinthera.2010.06.019. Clin Ther. 2010. PMID: 20678673 Free PMC article. Clinical Trial.
Lemborexant, A Dual Orexin Receptor Antagonist (DORA) for the Treatment of Insomnia Disorder: Results From a Bayesian, Adaptive, Randomized, Double-Blind, Placebo-Controlled Study.
Murphy P, Moline M, Mayleben D, Rosenberg R, Zammit G, Pinner K, Dhadda S, Hong Q, Giorgi L, Satlin A. Murphy P, et al. Among authors: satlin a. J Clin Sleep Med. 2017 Nov 15;13(11):1289-1299. doi: 10.5664/jcsm.6800. J Clin Sleep Med. 2017. PMID: 29065953 Free PMC article. Clinical Trial.
Neuropsychiatric signs and symptoms of Alzheimer's disease: New treatment paradigms.
Lanctôt KL, Amatniek J, Ancoli-Israel S, Arnold SE, Ballard C, Cohen-Mansfield J, Ismail Z, Lyketsos C, Miller DS, Musiek E, Osorio RS, Rosenberg PB, Satlin A, Steffens D, Tariot P, Bain LJ, Carrillo MC, Hendrix JA, Jurgens H, Boot B. Lanctôt KL, et al. Among authors: satlin a. Alzheimers Dement (N Y). 2017 Aug 5;3(3):440-449. doi: 10.1016/j.trci.2017.07.001. eCollection 2017 Sep. Alzheimers Dement (N Y). 2017. PMID: 29067350 Free PMC article. Review.
Rivastigmine in Alzheimer disease: efficacy over two years.
Grossberg G, Irwin P, Satlin A, Mesenbrink P, Spiegel R. Grossberg G, et al. Among authors: satlin a. Am J Geriatr Psychiatry. 2004 Jul-Aug;12(4):420-31. doi: 10.1176/appi.ajgp.12.4.420. Am J Geriatr Psychiatry. 2004. PMID: 15249280 Clinical Trial.
79 results